Recall

Johnson & Johnson to pull mesh implants from market

Johnson & Johnson has agreed to stop selling four types of vaginal mesh implants in response to mesh lawsuits from more than 600 women who claim the devices injured them.

According to Bloomberg, the company informed a federal judge in West Virginia that it intends to stop “commercializing” the implants. Bloomberg quotes a spokesman for Johnson & Johnson’s Ethicon unit as saying that sales of the devices will ...

continue reading...

Full-page ad calls for closing loophole

Consumers Union, the policy and advocacy arm of Consumer Reports, has placed a full-page print ad in Washington, D.C.-based publication Politico, calling on Congress to close a loophole that allows dangerous devices to make it on the market without clinical testing.

The ad is running as the U.S. Senate prepares to vote on a bill this week to reauthorize the statute governing medical device oversight.

It specifically makes reference to two medical ...

continue reading...

Feds want to question new J&J CEO in Risperdal fraud case

In a motion filed as part of a fraud case against Johnson & Johnson, the federal government alleges that new company CEO Alex Gorsky “was actively involved in matters at issue in this case,” Forbes reports.

Government prosecutors charge that Johnson & Johnson paid kickbacks to Omnicare, the nation’s largest nursing home pharmacy, to get Omnicare to pick up the antipsychotic medication Risperdal and other Johnson & Johnson drugs.

The federal government ...

continue reading...

FDA approval of transvaginal mesh based on device that was recalled

Lopez McHugh has learned that transvaginal mesh devices, which are causing women extreme pain due to mesh erosion, extrusion, and failure, was approved by the FDA because they were similar another device on the market that has been recalled due to problems.

Yet this approval process is not limited to transvaginal mesh devices. A number of consumer advocacy groups have criticized the U.S. Food and Drug Administration’s 510(k) approval process, ...

continue reading...

Doctor: No advantage to dangerous implant

In testimony before the U.S. Food and Drug Administration, Dr. Michael Carome called for a ban on all vaginal mesh products, on the grounds that they have no advantages over other forms of treatment, yet cause a host of severe health problems.

Mesh implants are used to treat urinary incontinence and pelvic organ prolapse – a condition that results when weakened muscles provide inadequate support for internal ...

continue reading...

Jury says Johnson & Johnson improperly marketed Risperdal

A jury in Arkansas ruled that Johnson & Johnson officials used deceptive tactics to market antipsychotic drug Risperdal, misleading doctors about the drug’s risks and improperly marketing it for unapproved uses, Bloomberg reports.

The decision in Arkansas marks the third such jury verdict against Johnson & Johnson over allegations that the pharmaceutical giant concealed Risperdal’s risks and tricked Medicaid regulators into paying more than they should have for the medication.

Juries also decided against the company in Louisiana and South Carolina.

A total ...

continue reading...
Page 24 of 26 «...10202223242526